4 neurofilament subunits (17) . Mice transgenic for p35, however, do not show a comparable phenotype, further arguing that activation of cdk5 by p25 severly disturbs neuronal function (20) .
Elevated calpain activity as a result of disturbances in cellular Ca 2+ -homeostasis has been linked to neuronal cell death in a variety of neurotoxic insults, ranging from ischemia to
Alzheimer's disease (21, 22) . Interestingly, calpain activity and p25 levels increased after treatment of neuronal cultures with neurotoxic fibrillary Aβ peptide, a primary constituent of the amyloid plaques found in the brains of patients with Alzheimer's disease (14) . Importantly, toxicity of Aβ peptide is partially blocked by pharmacological inhibitors and by antisense oligonucleotides to cdk5 (14, 23) . Taken together, these results indicate an important function of p25/cdk5 activity as a mediator of neuronal cell death downstream of calpain activation.
The detrimental effects of p25/cdk5 activity have been explained by an accompanying deregulation of cdk5 activity due to altered biological properties of p25 versus p35. p35 is rapidly degraded by ubiquitin-mediated proteolysis resulting in a half-life of ~20-30 minutes (24) . In contrast, p25 is 5-10-fold more stable which leads to a prolonged activation of cdk5 (18) .
In addition, p35 is enriched in peripheral membranes whereas p25 is predominantly localized to the cytoplasm, which probably sequesters cdk5 activity to compartments of the cell where it is normally not active (14, 15, 18) .
Both, p35 and p39 are expressed throughout the adult rat brain and have been implicated in the regulation of the neuronal cytoskeleton and synaptic function via the control of cdk5 activity (9, 10, (25) (26) (27) (28) (29) . However, expression patterns differ between p35 and p39 (9) and results from p35, p39 and cdk5 knockout mice indicate that p35 and p39 are non-redundant proteins (13) .
Therefore, any assessment about the regulation of cdk5 is incomplete without analysis of its by guest on http://www.jbc.org/ Downloaded from 5 regulation by p39. To address this question, we analyzed whether p39 is a substrate of calpain and whether such a cleavage event could aggravate deregulation of cdk5.
Here we show that p39 to p29 conversion is mediated by calpain in vitro and in vivo and that p29 differs markedly from p39 in its biological properties. Our results suggest that p29
contributes to deregulation of cdk5 activity induced by neurotoxic insults.
7
buffer each (50 mM HEPES, 100 mM NaCl, 10 mM DTT, 10% glycerol, 0.1% CHAPS and 5 Ischemia-Global ischemia was induced in adult C57BL/6J mice for 2 hours as described (31) .
Ischemic and control brains were dissected and dounce-homogenized in 5 ml of ice-cold ELB (50 mM Tris, 250 mM NaCl, 0.1% NP-40, pH 7) containing protease inhibitor cocktail (Roche) in a glass homogenizer. Lysates were cleared by centrifugation at 16,000 g for 10 minutes.
Pellets were re-homogenized in 2. was m-calpain-dependent, as it was completely blocked by the calpain-inhibitor calpeptin.
The kinase activation domain of p39 is contained in the C-terminal part of the protein (see Fig. 2D ). To analyze whether the C-terminus of p39 is present in p29, we produced C-terminally Flag-tagged p39 by IVT. p39C-Flag was then digested with recombinant m-calpain in the presence of 5 mM CaCl 2 . After Western blotting, the samples were probed with an antibody to the Flag-epitope (Fig. 1B) . The antibody recognized p29C-Flag generated upon addition of mcalpain. Only minor amounts of this fragment were detected in control incubations without mcalpain, most likely generated by endogenous calpain present in the reticulocyte lysate.
Therefore, the very C-terminus of p39 is contained in p29.
Next, we investigated whether p39 is cleaved directly by m-calpain. C-terminally His 6 -tagged p39 was produced using the baculovirus system and subsequently purified by Ni 2+ -column chromatography. This preparation was incubated with increasing amounts of recombinant mcalpain in the presence of 5 mM CaCl 2 and analyzed by SDS-PAGE and silver staining ( p29 is generated in ischemic brain-The results described so far demonstrated that p39 is a substrate for m-calpain in vitro. Next, we investigated whether conversion of p39 to p29 also occurs in vivo. p35 is converted to p25 after induction of ischemia in the brain (14, 16) . We subjected mouse brains to global ischemia and analyzed the obtained brain lysates for the generation of p29. Lysates were extracted from brains of untreated mice or mice which experienced 2 hours of global ischemia. Figure 2A shows that very little p29 can be detected in the lysates from untreated mice, whereas p29 was substantially increased in ischemic brain lysates. Calpain activity has been shown to be elevated after ischemia in the brain (21) . To control for calpain activity, we probed the blots for the well-defined calpain substrate nonerythroid α-spectrin, a 280 kDa protein (32) . Ischemia induced the cleavage of spectrin into the characteristic 145 and 150 kDa fragments, confirming that calpain was activated. Taken together, p29 is generated in vivo in ischemic brain concomitant with increased calpain activity.
The p29 fragment we detected in ischemic brain lysate was likely generated by an increase in calpain activity. To support this assumption, we carefully compared the size of the p29 species from ischemic brain with the size of p29 produced by in vitro digestion of p39 with recombinant m-calpain. As shown in Fig. 2B , p29 produced in ischemic brain corresponded precisely in size to p29 generated by in vitro digestion of IVT p39 with m-calpain. These results further suggest that calpain degrades p39 to p29 under ischemic conditions in the brain.
Determination of the m-calpain cleavage site in p39-We sought to determine at which site p39 is cleaved to p29 by m-calpain. To this end, we subjected p29 produced by m-calpain digestion of recombinant p39C-His 6 to N-terminal amino acid sequencing. The sequencing data suggested that Arg-101 in P1' position of p39 is a cleavage site for m-calpain, with additional cleavage sites existing at Arg-106 and Arg-109 in P1' (see Experimental Procedures). To support this observation, we expressed p29 starting at Arg-101 in COS-7 cells and found that it corresponded in size to endogenous p29 produced in ischemic brain (Fig. 2C) . The calculated molecular weight of this fragment is approximately 29 kDa (p29). This experiment shows that p39 is cleaved by m-calpain N-terminal of the kinase activation domain (Fig. 2D) . Therefore, p29 contains the entire kinase activation domain of p39.
The production of p29 in brain lysates is calpain-dependent-To further explore the possibility that calpain was the protease responsible for conversion of endogenous p39 to p29, we investigated whether calpain is required for this cleavage event. Lysates from adult mouse brains were prepared and incubated for increasing times with or without Ca 2+ and various protease inhibitors. Upon addition of 5 mM Ca 2+ , p29 was generated over time (Fig. 3A) . This fragment was identical in size to p29 detected in ischemic brain lysates. Without addition of Ca 2+ no accumulation of p29 was observed. As calpain is dependent on Ca 2+ -binding for activation of its protease activity (33) , this result supports an involvement of calpain in the p39 to p29
conversion. Indeed, production of p29 was blocked by the calpain inhibitors calpeptin (Fig. 3A) , calpain inhibitor I (ALLM), calpain inhibitor II (ALLN) and calpastatin (Fig. 3B) , when used at concentrations which have previously been shown to inhibit cleavage of p35 and α-spectrin by calpain in brain lysates (14) . In contrast, the caspase-3 inhibitor DEVD-CHO did not affect the generation of p29 despite the existence of a consensus site for this protease spanning Asp-109 to Asp-113 in p39. We noted that p29 became a slower migrating species with a fuzzy appearance after longer incubation periods. As this is a typical behavior of phosphorylated proteins after SDS-PAGE, p29 might become hyperphosphorylated with time. In conclusion, these experiments show that the generation of p29 in mouse brain lysate is mediated by calpain.
Neurotoxicity induces calpain-mediated generation of p29 in neuronal cultures-Our results
from ischemic brain lysates as well as from in vitro brain lysate assays suggested that p39 to p29 conversion lies downstream of calpain activation. Calpain activity in rat embryonic cortical cultures is increased after treatment with the Ca
2+
-ionophore ionomycin or the excitotoxin glutamate (14, 21) . In light of these reports, we treated 3-4 week old rat embryonic cultures with either ionomycin or glutamate to determine whether p29 was produced in these conditions.
Calpain activity was evaluated by probing for cleavage of non-erythroid α-spectrin. Treatment of cortical neuronal cultures with 5 µM ionomycin for 1 hour (Fig. 4A ) as well as 500 µM glutamate for 6 hours (Fig. 4B ) led to the cleavage of spectrin into 145 and 150 kDa breakdown products, showing that calpain was activated. In the same lysates, we observed increased generation of p29, suggesting that this cleaveage event was mediated by calpain. Accordingly, ionomycin-induced p39 to p29 conversion was blocked by the calpain inhibitor calpeptin, when calpeptin was applied in concentrations which have been shown to inhibit spectrin and p35
cleavage by calpain in neurons (14) . The same result was obtained by using calpain inhibitor I and II. Inhibition of calpain activity was confirmed by the lack of spectrin breakdown products in these lysates. In glutamate-treated cultures, inhibition of calpain activity with calpeptin also prevented an increase in the p29/p39 ratio. Control lysates from ischemic brain showed that p29 generated upon both neurotoxic insults corresponded in size to p29 produced after ischemia. In p29 has an increased half-life compared to p39-As p39 to p29 conversion occurs in vivo, we next attempted to determine whether p29 has different biological properties compared to p39.
We had shown recently that p25 is more stable than p35 when analyzed in transfected COS-7 cells, resulting in prolonged activation of cdk5 (18) . To test for the half-life of p29, we expressed human or mouse p29 or p39 together with cdk5 in COS-7 cells. Sixteen hours after transfection, cycloheximide was added to the cells for increasing periods of time before they were harvested and analyzed for expression of p29 or p39. Human and mouse p39 are short-lived proteins, which became almost completely degraded within 30 minutes of cycloheximide treatment (Fig.   5 ). In contrast, human and mouse p29 were still readily detectable when protein synthesis was inhibited for 2 hours. As expression levels of p39 and p29 were comparable before addition of cycloheximide, p29 is at least 4 times more stable than p39. These observations indicate that generation of p29 leads to prolonged activation of cdk5.
p29 causes redistribution of cdk5-Both, p39 and p35 contain a N-terminal myristoylation motif, encompassing a glycine as a second residue. This motif is important for the proper cellular localization of p35 (18) . p25, which lacks the N-terminus of p35, displays an altered subcellular distribution compared to p35. Cleavage of p39 by calpain results in the removal of its N-terminal domain including the myristoylation motif (see Fig. 2D ). In light of this observation, we sought to determine whether the subcellular distribution of p29 differs from p39. We expressed p39 and p29 in COS-7 cells and analyzed their localization by staining with an antibody to p39 (Fig. 6A ).
Staining for p39 was evident in the cell periphery and the cytoplasm. In contrast, p29 was mostly absent from the cell periphery but showed a homogenous staining throughout the cell soma.
DISCUSSION
The following cumulative evidence suggests direct cleavage of p39 to p29 by calpain in vivo:
(i) purified p39 is cleaved to p29 by recombinant m-calpain; (ii) p29 generated in ischemic brain and in cultures of primary cortical neurons has the same size as p29 produced by calpain cleavage of p39 in vitro. Production of discrete proteolytic fragments of its substrates is a characteristic of calpain (32); (iii) p39 to p29 conversion in mouse brain lysates is dependent on neurons (14) (15) (16) . Based on studies in knockout mice, p35 and p39 are major activators of cdk5 in the brain (13) . Both activators are expressed throughout the brain in adult rats (9, 34) . Therefore, subsequent processing of p35 and p39 through activation of calpain potentially affects overall cdk5 signaling in the vast majority of neurons in the brain.
p29 is derived from the C-terminus of p39 (Fig. 2D) . p25, which contains C-terminal aa 99-307 of human p35, activates cdk5 in vivo (17) . In addition, a fragment containing aa 150-307 of human p35 has been shown to fold into a cyclin-like structure and to activate cdk5 in in vitro kinase assays (8, 35, 36) . The cdk5-activation domain of p35 is conserved in p29 (Fig. 2D) , which indicates that p29 is capable of activating cdk5. Indeed, a N-terminally truncated form of p39 starting at Gly-115 was found to activate cdk5 in in vitro kinase assays (7), suggesting that p29 similar to p25 activates cdk5.
We recently proposed a model in which increased generation of p25 leads to deregulation of cdk5 (18) . This model was based on our observation that p25 differs from p35 in stability and cellular localization, resulting in prolonged activation and mislocalization of cdk5, and eventually neuronal cell death. We now describe that p39 is cleaved by calpain to p29 after neurotoxic insults (Fig. 2 and 4) . In addition, p29 is more stable and has a different cellular localization compared to p39 (Fig. 5 and 6 ). This indicates that cdk5 activity becomes deregulated downstream of calpain activation by increased production of p29 in addition to p25.
Studies which have shown direct involvement of cdk5 activity as a mediator of neuronal cell death after neurotoxic insults have, however, not distinguished between p35/p25 or p39/p29-mediated activation (14, 23) . Interestingly, although p35 and p39 are expressed throughout the adult nervous system, differences do exist in expression levels in different neuronal populations.
Accordingly, the extent of deregulation of cdk5 by either p29 or p25 potentially differs in specific subsets of neurons. For example, p39 levels are high in the spinal cord (9) . Recently, elevated levels of p25 and cdk5 activity have been described in the spinal cord of transgenic mice expressing mutant superoxide dismutase 1 (SOD1) (19) . This mutation was identified in patients with familial amyotrophic lateral sclerosis (ALS), which is characterized by severe motor neuron degeneration. It would be interesting to determine whether p29 is accumulated and to what extent it contributes to increased cdk5 activity in spinal cords of mutant SOD1 transgenic mice.
Does cleavage of p35/p39 occur under pathological conditions only or could it be a physiological signaling event which regulates cdk5 activity? On one hand, increases in calpain activity are believed to contribute to cell death due to widespread degradation of substrates like cytoskeletal proteins (32) . On the other, calpain function has been implicated in a number of 20 physiological processes, e.g. synaptic plasticity (37) . The difference between physiological or pathological action of calpain would therefore be determined by the extent to which intracellular Ca 2+ -levels are altered (21) . p35/cdk5 and p39/cdk5 have been implicated in regulation of the neuronal actin cytoskeleton as well as synaptic signaling (2), both processes which are regulated by Ca 2+ (38, 39) . Cleavage of p35 and p39 by Ca
2+
-activated calpain and subsequent changes in cdk5 signaling might be involved in the regulation of these processes. Although we did occasionally detect minute amounts of p29 in fresh brain lysates, it is unclear whether this represents the situation in vivo, as calpain is known to become rapidly activated in post-mortem brains (40) . To address this issue, experiments will be necessary which allow detection of calpain-mediated processing of p35/p39 in situ.
p35 and p39 are cleaved by calpain in the N-terminal domain in a region which is not conserved between the two activators (14) . It has been suggested that substrate specificity of calpain is conferred by recognition of higher order structures rather than consensus sites composed of few amino acids (41) (42) (43) . This is supported by lack of similarity between the cleavage sites of various calpain substrates identified to date (44, 45) . Whereas the N-terminus of p35 and p39 seems rather unstructured, the C-terminal kinase activation domain folds into a cyclin-like structure and is highly conserved (36) . Recognition of this domain by calpain might therefore explain why both activators are a substrate for this protease. Neurons were lysed after 6 hours and samples were examined as described in A. Glutamate 
